Standout Papers

Rosuvastatin to Prevent Vascular Events ... 1985 2026 1998 2012 4.6k
  1. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein (2008)
    Paul M. Ridker, Eleanor Danielson et al. New England Journal of Medicine
  2. Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein (2009)
    Paul M. Ridker, Eleanor Danielson et al. Obstetrical & Gynecological Survey
  3. Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells (2000)
    Vincenzo Pasceri, James T. Willerson et al. Circulation
  4. Circadian Variation in the Frequency of Onset of Acute Myocardial Infarction (1985)
    James E. Muller, Peter H. Stone et al. New England Journal of Medicine
  5. Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure (2003)
    Eugene S. Chung, Milton Packer et al. Circulation
  6. Inflammation as a Cardiovascular Risk Factor (2004)
    James T. Willerson, Paul M. Ridker Circulation
  7. Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure (2003)
    Emerson C. Perin, Hans Fernando Rocha Dohmann et al. Circulation
  8. The VIVA Trial (2003)
    Timothy D. Henry, Brian H. Annex et al. Circulation
  9. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial (2009)
    Paul M. Ridker, Eleanor Danielson et al. The Lancet
  10. Appointment of New Associate Editor for Circulation (1996)
    James T. Willerson Circulation
  11. Modulation of C-Reactive Protein–Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs (2001)
    Vincenzo Pasceri, James T. Willerson et al. Circulation
  12. Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model (2005)
    Guilherme V. Silva, Silvio Litovsky et al. Circulation
  13. A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism (2009)
    Robert J. Glynn, Eleanor Danielson et al. New England Journal of Medicine
  14. Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart Disease (1981)
    Paul D. Hirsh, L.David Hillis et al. New England Journal of Medicine
  15. Risk factors for sudden death after acute myocardial infarction: Two-year follow-up (1984)
    Jhulan Mukharji, Robert E. Rude et al. The American Journal of Cardiology

Immediate Impact

1 by Nobel laureates 10 from Science/Nature 102 standout
Sub-graph 1 of 18

Citing Papers

YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS–STING
2022 StandoutNature
The changing landscape of atherosclerosis
2021 StandoutNature
17 intermediate papers

Works of James T. Willerson being referenced

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
2009 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
and 9 more

Author Peers

Author Last Decade Papers Cites
James T. Willerson 20757 8075 16670 9139 628 47.0k
Stephen E. Epstein 28307 7980 10871 7886 523 45.6k
Amir Lerman 26356 10719 14635 7825 868 49.5k
Lina Badimón 13534 3455 11516 7631 685 34.1k
Thomas F. Lüscher 27493 5875 13292 11328 1.1k 61.0k
Hugo A. Katus 37529 8906 11617 15861 1.4k 57.5k
Toyoaki Murohara 13705 2563 10836 17731 1.2k 44.1k
Michael Böhm 38042 2993 14032 11785 1.1k 61.0k
Ulf Landmesser 14767 3793 10458 6836 558 32.9k
Dirk J. van Veldhuisen 42486 3064 7636 5629 852 58.8k
Gerhard Schüler 24879 7527 12051 5240 646 39.8k

All Works

Loading papers...

Rankless by CCL
2026